Received: from MN2PR04MB6143.namprd04.prod.outlook.com (2603:10b6:208:e6::29)
 by MN2PR04MB5550.namprd04.prod.outlook.com with HTTPS; Fri, 18 Sep 2020
 19:26:39 +0000
Authentication-Results: microsoft.com; dkim=none (message not signed)
 header.d=none;microsoft.com; dmarc=none action=none
 header.from=BWH.HARVARD.EDU;
Received: from MN2PR04MB5966.namprd04.prod.outlook.com (2603:10b6:208:e6::31)
 by MN2PR04MB6143.namprd04.prod.outlook.com (2603:10b6:208:e6::29) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.3391.14; Fri, 18 Sep
 2020 19:26:38 +0000
Received: from MN2PR04MB5966.namprd04.prod.outlook.com
 ([fe80::98f6:ed8:eb69:99c2]) by MN2PR04MB5966.namprd04.prod.outlook.com
 ([fe80::98f6:ed8:eb69:99c2%7]) with mapi id 15.20.3391.015; Fri, 18 Sep 2020
 19:26:38 +0000
From: "Lauffenburger, Julie,PHARM.D.,Ph.D." <JLAUFFENBURGER@BWH.HARVARD.EDU>
To: Marco Rossi <Marco.Rossi@microsoft.com>, Elad Yom-Tov
	<eladyt@microsoft.com>, "Bessette, Lily Gui" <lgbessette@bwh.harvard.edu>
CC: "Fontanet, Constance P." <cfontanet@bwh.harvard.edu>
Subject: RE: Roybal RL meeting tomorrow at 11:30a EST
Thread-Topic: Roybal RL meeting tomorrow at 11:30a EST
Thread-Index: AdaGzjA/qesp2JcEQRmjiiUtuqRnggFkXswAACOHh8AAPSzQIAADk3eg
Date: Fri, 18 Sep 2020 19:26:38 +0000
Message-ID:
 <MN2PR04MB5966C0501071ADFD6BBEB730853F0@MN2PR04MB5966.namprd04.prod.outlook.com>
References:
 <MN2PR04MB5966287EBBABFFB312A744F085260@MN2PR04MB5966.namprd04.prod.outlook.com>
 <E1BF4B74-4C03-4133-B44F-DB272465F271@bwh.harvard.edu>
 <VI1PR83MB0240189E40F4AD35AD014574C03E0@VI1PR83MB0240.EURPRD83.prod.outlook.com>
 <SN6PR2101MB0974A3E9052A7A01B5585257E93F0@SN6PR2101MB0974.namprd21.prod.outlook.com>
In-Reply-To:
 <SN6PR2101MB0974A3E9052A7A01B5585257E93F0@SN6PR2101MB0974.namprd21.prod.outlook.com>
Accept-Language: en-US
Content-Language: en-US
X-MS-Has-Attach: yes
X-MS-Exchange-Organization-SCL: -1
X-MS-TNEF-Correlator:
 <MN2PR04MB5966C0501071ADFD6BBEB730853F0@MN2PR04MB5966.namprd04.prod.outlook.com>
MIME-Version: 1.0
X-MS-Exchange-Organization-MessageDirectionality: Originating
X-MS-Exchange-Organization-AuthSource: MN2PR04MB5966.namprd04.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Internal
X-MS-Exchange-Organization-AuthMechanism: 04
X-Originating-IP: [98.217.178.208]
X-MS-Exchange-Organization-Network-Message-Id:
 200491e2-1b05-46ec-6186-08d85c08c3c1
X-MS-PublicTrafficType: Email
Return-Path: JLAUFFENBURGER@BWH.HARVARD.EDU
X-MS-Exchange-Organization-ExpirationStartTime: 18 Sep 2020 19:26:38.7108
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Office365-Filtering-Correlation-Id: 200491e2-1b05-46ec-6186-08d85c08c3c1
X-MS-TrafficTypeDiagnostic: MN2PR04MB6143:
X-MS-Exchange-Transport-Forked: True
X-MS-Oob-TLC-OOBClassifiers: OLM:10000;
X-Microsoft-Antispam: BCL:0;
X-Forefront-Antispam-Report:
 CIP:255.255.255.255;CTRY:;LANG:en;SCL:-1;SRV:;IPV:NLI;SFV:SKI;H:MN2PR04MB5966.namprd04.prod.outlook.com;PTR:;CAT:NONE;SFS:;DIR:INB;
X-MS-Exchange-AntiSpam-MessageData:
 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
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 18 Sep 2020 19:26:38.5929
 (UTC)
X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted
X-MS-Exchange-CrossTenant-Id: 720edb1f-5c4e-4043-8141-214a63a7ead5
X-MS-Exchange-CrossTenant-AuthSource: MN2PR04MB5966.namprd04.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-Network-Message-Id: 200491e2-1b05-46ec-6186-08d85c08c3c1
X-MS-Exchange-CrossTenant-MailboxType: HOSTED
X-MS-Exchange-CrossTenant-UserPrincipalName: GMNSKbFncgE/a/eF5rJu21SPY/MVpe3sIEwiKu06eWTTFeHxDE2KnW8KFSVMmYAC14QEzasE7aWcMNIM+vX/nxEd1tA1shvW1jaMEf6Dgnc=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: MN2PR04MB6143
X-MS-Exchange-Transport-EndToEndLatency: 00:00:00.5387897
X-MS-Exchange-Processed-By-BccFoldering: 15.20.3391.014
X-Microsoft-Antispam-Mailbox-Delivery:
	ucf:0;jmr:0;auth:0;dest:I;ENG:(750128)(520011016)(706158)(944506458)(944626604);
X-Microsoft-Antispam-Message-Info:
	khbP5QkhbI4CZLDCeS+d9OphyW+fWMXW3nVL/2Sowjlhnceq5rzMZaj4Nw5qxp4wxlr/bw6Sxe8UnmuDYzSqgfAIVJrzvgqy6KgwYHcBKOSU4qgUczi9rotUKw4wkuI42FIsYppskfAR6F59PibFLE14lSEpZGX0RwCEWPzmo9jKwlwU09kk59H6ahipi4DaqGfDL8qwLLTw8vWxbUFEyOBH8UoMxx1W4DupAol5phHZYELMocDBPAM1gds8IbZbtBee+cpAfX0GOrbJj+sp78ZwnuPXMMc3EGIT02iVY8FQkkML18yLou04j8gHJZz2rVpyIPxZ01YQB6MN953qvN8TP2ycuOZXO1JzNiyjOWy/pLj6cdI6GjF0XZlGWJs0jOXVj5no09KNt78ziw8PGmca225B7C5XtUZpmToEUeQ=
Content-type: multipart/mixed;
	boundary="B_3687283027_1649149280"

> This message is in MIME format. Since your mail reader does not understand
this format, some or all of this message may not be legible.

--B_3687283027_1649149280
Content-type: multipart/alternative;
	boundary="B_3687283027_1678704601"


--B_3687283027_1678704601
Content-type: text/plain;
	charset="UTF-8"
Content-transfer-encoding: quoted-printable

Hi Marco, Elad,

=20

Thanks so much! I agree, I think having a meeting to go over the features a=
nd how to model them would be extremely helpful (that is one of the biggest =
questions I=E2=80=99ve been having). I know in traditional prediction models it=E2=80=99=
s a major consideration (i.e., 7 observations/predictor sometimes), but was =
not sure how it applied here.=20

=20

Could we meet sometime next week on this? From our side, looks like any of =
the following would work (Lily I included your availability):

Monday (9/21) 9a-10:30am and 1-2pm EST

Tuesday (9/22) 10a-11a, 12:30p-1p EST
Wednesday (9/23) 9a-10a, 11:30a-2pm EST

Thursday (9/24) 9a-11a EST

Friday (9/25) 12:30p-3p EST

=20

Thanks!

Julie

=20

From: Marco Rossi <Marco.Rossi@microsoft.com>=20
Sent: Friday, September 18, 2020 2:02 PM
To: Elad Yom-Tov <eladyt@microsoft.com>; Bessette, Lily Gui <lgbessette@bwh=
.harvard.edu>
Cc: Fontanet, Constance P. <cfontanet@bwh.harvard.edu>; Lauffenburger, Juli=
e,PHARM.D.,Ph.D. <JLAUFFENBURGER@BWH.HARVARD.EDU>
Subject: RE: Roybal RL meeting tomorrow at 11:30a EST

=20

        External Email - Use Caution       =20

Hi All,

Thank you Elad for adding me to the thread.

=20

My answers in blue below. Let me know if they make sense.

=20

Thanks,

Marco

=20

From: Elad Yom-Tov <eladyt@microsoft.com>=20
Sent: Thursday, September 17, 2020 6:29 AM
To: Bessette, Lily Gui <lgbessette@bwh.harvard.edu>; Marco Rossi <Marco.Ros=
si@microsoft.com>
Cc: Fontanet, Constance P. <cfontanet@bwh.harvard.edu>; Lauffenburger, Juli=
e,PHARM.D.,Ph.D. <JLAUFFENBURGER@BWH.HARVARD.EDU>
Subject: RE: Roybal RL meeting tomorrow at 11:30a EST

=20

Hi Lily,

=20

(Adding Marco to the thread)

=20

@Marco Could you address questions 1, 2, 4 below?

=20

My answers are below, in red.

=20

Thanks,

=20

Elad

=20

From: Bessette, Lily Gui <lgbessette@bwh.harvard.edu>=20
Sent: Thursday, 17 September 2020 2:29
To: Elad Yom-Tov <eladyt@microsoft.com>
Cc: Fontanet, Constance P. <cfontanet@bwh.harvard.edu>; Lauffenburger, Juli=
e,PHARM.D.,Ph.D. <JLAUFFENBURGER@BWH.HARVARD.EDU>
Subject: Re: Roybal RL meeting tomorrow at 11:30a EST

=20

Hi Elad,

=20

I=E2=80=99m starting to code everything for the Reinforcement Learning Project an=
d I have a few questions that have come up.

=20
First, we were wondering if categorizing the features with Namespaces makes=
 any difference to the model and if so, what are the advantages and disadvan=
tages in doing so? (https://docs.microsoft.com/en-us/azure/cognitive-service=
s/personalizer/concepts-features#categorize-features-with-namespaces)=20
Namespaces are a way to group features for user readability and to perform =
on-the-fly feature engineering across namespaces. There is no disadvantage t=
o using them, with Personalizer you must use them because the formatting of =
the json is important. Advantages are the on-the-fly feature engineering. Ex=
amples of this:
Crossing all the features belonging to two namespaces: --quadratic AB or --=
cubic ABC (where A, B, and C are the initials, case-sensitive, of the two/th=
ree namespaces). Higher order crossing is also available.
Ignore a namespace: --ignore A (A is the initial of the namespace to be ign=
ored)
=20
Additionally, in terms of denseness of our features, should we convert any =
of our continuous variables i.e. Age, HbA1c, etc. into buckets/categorical v=
ariables? Or are they okay as-is as continuous variables? (https://docs.micr=
osoft.com/en-us/azure/cognitive-services/personalizer/concepts-features#make=
-features-more-dense)
This is a very important decision. Performance of the algo will be determin=
ed by how we featurize these variables, and these decisions will determine t=
he ML model size. In general, since we will be operating in the very low dat=
a regime, having a small model is probably a must for our scenario. We can s=
chedule a meeting to go over all the features and take an initial decision o=
n how to featurize them.=20
We also wanted to confirm that the =E2=80=9Chidden factors for evaluation=E2=80=9D are =
not incorporated anywhere in the Rank calls of within the contextFeatures. i=
.e. These are only for post study analysis and will not contribute to the te=
xt message choices.
That is correct.
Another clarification I had is whether eventIDs with missing/null reward va=
lues automatically get assumed to be 0 in Personalizer. Yes, this is correct=
. Therefore, if a patient is missing all doses for a day =E2=80=93 i.e. reward res=
ult of 0 =E2=80=93 then should I not send the Reward call of 0 for that eventID in=
case it is due to a technological glitch (i.e. loss of internet connection) =
and we want to update the Reward appropriately if data later becomes availab=
le? In general, what should happen when we=E2=80=99re missing pill bottle data for=
 a patient?
If patient is missing all doses, then you don=E2=80=99t need to call the reward A=
PI. A default reward of 0 will be joined when the Reward Window expires. Onc=
e that window expires you cannot send a new reward.

How to deal with a technological glich is a good question. First of all, do=
 we have visibility over these kind of communication errors?

Again confirming the sequential approach to our rank calls:
Rank call for Framing =E2=80=93 Pos/Neg/Neutral
Receive and add resulting Framing choice/response from RankRequest call to =
Context Features
Rank call for History =E2=80=93 Y/N
Receive and add resulting History choice/response from RankRequest call to =
Context Features
Rank call for Social =E2=80=93 Y/N
Receive and add resulting Social choice/response from RankRequest call to C=
ontext Features
Rank call for Content =E2=80=93 Y/N
Receive and add resulting Content choice/response from RankRequest call to =
Context Features
Rank call for Reflective =E2=80=93 Y/N
Receive resulting Reflective choice/response from RankRequest call.
Use resulting combination of framing, history, social, content, reflective =
action responses to choose the unique factor set of text messages.
Randomly choose one out of the two/three messages in that unique factor set=
.
Record this data and output the chosen text message for this eventID.
Use this data to update number of days since each type (framing/history/soc=
ial/content/reflective) of message was sent.
This is correct.
For @Julie, to think on, we=E2=80=99re also debating whether we should have which=
 medications they are using as part of the contextFeatures =E2=80=93 i.e. Metformi=
n Yes/No due to variations in pill size etc. and their possible influence on=
 adherence.=20
Also, more of a @Julie question, I thought about the calendar day idea for =
assessing reward result. To confirm, we are saying that if a patient took th=
eir medication appropriately (i.e. all doses) on 9/16/2020 and the text mess=
age was sent on 9/16/2020, then reward is 1. It is NOT if the text message w=
as sent on 9/15/2020 and then the patient took all their doses appropriately=
 on 9/16/2020 that we are evaluating, correct? My other thought here is, do =
we care if the text message (i.e. 5pm 9/16/2020) was received later on the s=
ame day that they took their medication (i.e. 6am 9/16/2020)? Just thinking =
through the timing of everything to make sure I=E2=80=99m not missing something in=
 regards to choosing a 24 hr window vs a calendar day assessment for reward.=
=20
=20

Let me know if any of this doesn=E2=80=99t make sense and if you=E2=80=99d prefer to me=
et via Zoom to discuss.

=20

Thank you!

Best,
Lily

=20

Lily Bessette
Project Coordinator=20
Division of Pharmacoepidemiology and Pharmacoeconomics=20
Department of Medicine=20
Brigham and Women's Hospital  | Harvard Medical School

41 Avenue Louis Pasteur,  Suite 116, Boston, MA 02115

p. (617) 264-3099 | lgbessette@bwh.harvard.edu |Research Assistant Request =
Form

=20

From: "Lauffenburger, Julie,PHARM.D.,Ph.D." <JLAUFFENBURGER@BWH.HARVARD.EDU=
>
Date: Wednesday, September 9, 2020 at 1:39 PM
To: "McDonnell, Marie E.,M.D." <MMCDONNELL@BWH.HARVARD.EDU>, "Choudhry, Nit=
eesh Kumar,M.D.,Ph.D." <NKCHOUDHRY@BWH.HARVARD.EDU>, Elad Yom-Tov <eladyt@mi=
crosoft.com>, "Keller, Punam A." <Punam.A.Keller@tuck.dartmouth.edu>
Cc: "Barlev, Renee A." <rbarlev@bwh.harvard.edu>, "Haff, Nancy,M.D." <NHAFF=
@PARTNERS.ORG>, "philip.rosenfield@microsoft.com" <philip.rosenfield@microso=
ft.com>, "Hanken, Kaitlin Elizabeth" <khanken@bwh.harvard.edu>, "Sears, Elle=
n Sawka" <essears@bwh.harvard.edu>, "Fontanet, Constance P." <cfontanet@bwh.=
harvard.edu>, "Kim, Erin" <ekim55@bwh.harvard.edu>, "Bessette, Lily Gui" <lg=
bessette@bwh.harvard.edu>
Subject: Roybal RL meeting tomorrow at 11:30a EST

=20

Hi everyone,

=20

I hope you all are doing well. We=E2=80=99re planning to use our 30 minutes tomor=
row to review the algorithm development within the Azure platform. If you ha=
ve interested in attending, feel free, but the plan is to focus on that. Tha=
nks!

=20

Other study updates:
All regulatory, IRB, and RISO approvals have been obtained.
We=E2=80=99ve received the pillbottles and pillbottle caps! Everything with regar=
d to mailing the pillbottles is basically ready to go.
The text messaging platform environment is being set up for us now (and tex=
t messages have been finalized). We expect to set up the texts within the ne=
xt few weeks.
The REDCap database and other patient recruitment components are in process=
, nearing completion.=20
=20

I=E2=80=99ve also included our minutes from last time. Thanks!

=20

Best,

Julie=20

=20

--

Julie Lauffenburger, PharmD, PhD

617-525-8865

jlauffenburger@bwh.harvard.edu

=20

From: Lauffenburger, Julie,PHARM.D.,Ph.D.=20
Sent: Tuesday, September 01, 2020 4:42 PM
To: McDonnell, Marie E.,M.D. <MMCDONNELL@BWH.HARVARD.EDU>; Choudhry, Nitees=
h Kumar,M.D.,Ph.D. <NKCHOUDHRY@BWH.HARVARD.EDU>; 'Elad Yom-Tov' <eladyt@micr=
osoft.com>; 'Keller, Punam A.' <Punam.A.Keller@tuck.dartmouth.edu>
Cc: Barlev, Renee A. <rbarlev@bwh.harvard.edu>; Haff, Nancy,M.D. <NHAFF@PAR=
TNERS.ORG>; 'philip.rosenfield@microsoft.com' <philip.rosenfield@microsoft.c=
om>; Hanken, Kaitlin Elizabeth <khanken@bwh.harvard.edu>; Sears, Ellen Sawka=
 <essears@bwh.harvard.edu>; Fontanet, Constance P. <cfontanet@bwh.harvard.ed=
u>; Kim, Erin <ekim55@bwh.harvard.edu>
Subject: Updated text messages for our Roybal pilot

=20

Hi all,

=20

I=E2=80=99m attaching the updated, hopefully close to final, version of the text =
messages for our Roybal pilot. Many thanks to all who gave input and helped =
draft messages, especially Punam, Kaitlin, and Constance on this round! Any =
questions, please let me know.

=20

Best,

Julie=20

=20

--

Julie Lauffenburger, PharmD, PhD

617-525-8865

jlauffenburger@bwh.harvard.edu

=20

From: Lauffenburger, Julie,PHARM.D.,Ph.D.=20
Sent: Wednesday, August 12, 2020 11:00 AM
To: McDonnell, Marie E.,M.D. <MMCDONNELL@BWH.HARVARD.EDU>; Choudhry, Nitees=
h Kumar,M.D.,Ph.D. <NKCHOUDHRY@BWH.HARVARD.EDU>; Elad Yom-Tov <eladyt@micros=
oft.com>; Keller, Punam A. <Punam.A.Keller@tuck.dartmouth.edu>
Cc: Barlev, Renee A. <rbarlev@bwh.harvard.edu>; Haff, Nancy,M.D. <NHAFF@PAR=
TNERS.ORG>; philip.rosenfield@microsoft.com; Hanken, Kaitlin Elizabeth <khan=
ken@bwh.harvard.edu>; Sears, Ellen Sawka <essears@bwh.harvard.edu>; Fontanet=
, Constance P. <cfontanet@bwh.harvard.edu>; Kim, Erin <ekim55@bwh.harvard.ed=
u>
Subject: Roybal Reinforcement learning meeting tomorrow at 1pm EST

=20

Dear team,

=20

I=E2=80=99m looking forward to our Reinforcement learning meeting tomorrow (Thurs=
, 1pm EST). I=E2=80=99ve attached the minutes from our last full call, proposed te=
xt messages for review, and a list of potential predictors for discussion.=20

=20

Proposed agenda:
Brief study updates
Pillsy pillbottles
Text messaging platform
Algorithm development
Discussion points
Review proposed text messages (attachment)=20
Clarify prediction model inputs/elements (attachment)
=20

Thanks! Any questions, let me know.

=20

Best,

Julie=20

=20

--

Julie Lauffenburger, PharmD, PhD

617-525-8865

jlauffenburger@bwh.harvard.edu

=20

From: Lauffenburger, Julie,PHARM.D.,Ph.D.=20
Sent: Thursday, August 06, 2020 10:41 AM
To: McDonnell, Marie E.,M.D. <MMCDONNELL@BWH.HARVARD.EDU>; Choudhry, Nitees=
h Kumar,M.D.,Ph.D. <NKCHOUDHRY@BWH.HARVARD.EDU>; Elad Yom-Tov <eladyt@micros=
oft.com>; Keller, Punam A. <Punam.A.Keller@tuck.dartmouth.edu>
Cc: Barlev, Renee A. <rbarlev@bwh.harvard.edu>; Haff, Nancy,M.D. <NHAFF@PAR=
TNERS.ORG>; philip.rosenfield@microsoft.com; Hanken, Kaitlin Elizabeth <khan=
ken@bwh.harvard.edu>; Sears, Ellen Sawka <essears@bwh.harvard.edu>; Fontanet=
, Constance P. <cfontanet@bwh.harvard.edu>; Kim, Erin <ekim55@bwh.harvard.ed=
u>
Subject: Roybal Reinforcement learning text messages for review

=20

Dear team,

=20

We=E2=80=99ve been hard at work on the text messages! I=E2=80=99ve attached the list of=
 proposed text messages for your review (Excel). We=E2=80=99re hoping to finalize =
these as best as possible after our meeting next Thursday (8/13).=20

=20

Notes:
We are going with 5 main factors (Framing, Observed feedback, Social, Conte=
nt, Reflective) =C3=A0 this means we need at least 48 unique text messages to me=
et all those levels.
For each level, we added a second message, so that there could be more vari=
ation, bringing us to a total of 96 messages.
Observed feedback: We decided to stick with the past 7 days for simplicity.
The =E2=80=9CHidden=E2=80=9D factors are other variables that could be evaluated post-h=
oc, so each message is also coded for whether it meets any of those criteria=
 (for example: quantitative or doctor), but we do not have to have unique me=
ssages for these.
=20

Specific ask: Please review these messages and suggest any modifications; m=
ost happy to also entertain other options or replacements!

=20

Huge thanks to Kaitlin, Ellen, Constance, and our other RA, Erin, for their=
 help with these! I=E2=80=99ve also attached our July meeting minutes as a refresh=
er. Any questions, please let me know. Thank you!

=20

Best,

Julie=20

The information in this e-mail is intended only for the person to whom it i=
s addressed. If you believe this e-mail was sent to you in error and the e-m=
ail contains patient information, please contact the Mass General Brigham Co=
mpliance HelpLine at http://www.massgeneralbrigham.org/complianceline . If t=
he e-mail was sent to you in error but does not contain patient information,=
 please contact the sender and properly dispose of the e-mail.


--B_3687283027_1678704601
Content-type: text/html;
	charset="UTF-8"
Content-transfer-encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-microsof=
t-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word" xmlns:m=
=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"http://www.w3.org=
/TR/REC-html40"><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dutf-8"><meta na=
me=3D"Generator" content=3D"Microsoft Word 15 (filtered medium)"><!--[if !mso]><=
style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:#0563C1;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-priority:99;
	color:#954F72;
	text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.msonormal0, li.msonormal0, div.msonormal0
	{mso-style-name:msonormal;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.EmailStyle19
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle23
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle24
	{mso-style-type:personal-compose;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
.MsoChpDefault
	{mso-style-type:export-only;
	font-size:10.0pt;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
/* List Definitions */
@list l0
	{mso-list-id:256863052;
	mso-list-type:hybrid;
	mso-list-template-ids:-295672246 102164840 67698691 67698693 67698689 6769=
8691 67698693 67698689 67698691 67698693;}
@list l0:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:Calibri;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1
	{mso-list-id:1034768920;
	mso-list-type:hybrid;
	mso-list-template-ids:-963102186 -1508189236 67698691 67698693 67698689 67=
698691 67698693 67698689 67698691 67698693;}
@list l1:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:Calibri;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2
	{mso-list-id:1090926425;
	mso-list-type:hybrid;
	mso-list-template-ids:-1356024634 542657286 67698691 67698693 67698689 676=
98691 67698693 67698689 67698691 67698693;}
@list l2:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:Calibri;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3
	{mso-list-id:1982542364;
	mso-list-type:hybrid;
	mso-list-template-ids:1133538934 67698689 67698703 67698693 67698689 67698=
691 67698693 67698689 67698691 67698693;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l3:level2
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]--></head><body lang=3D"EN-US" link=3D"#0563C1" =
vlink=3D"#954F72"><div class=3D"WordSection1"><p class=3D"MsoNormal">Hi Marco, Ela=
d,<o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNorm=
al">Thanks so much! I agree, I think having a meeting to go over the feature=
s and how to model them would be extremely helpful (that is one of the bigge=
st questions I=E2=80=99ve been having). I know in traditional prediction models it=
=E2=80=99s a major consideration (i.e., 7 observations/predictor sometimes), but w=
as not sure how it applied here. <o:p></o:p></p><p class=3D"MsoNormal"><o:p>&n=
bsp;</o:p></p><p class=3D"MsoNormal">Could we meet sometime next week on this?=
 From our side, looks like any of the following would work (Lily I included =
your availability):<o:p></o:p></p><p class=3D"MsoNormal">Monday (9/21) 9a-10:3=
0am and 1-2pm EST<o:p></o:p></p><p class=3D"MsoNormal">Tuesday (9/22) 10a-11a,=
 12:30p-1p EST<br>Wednesday (9/23) 9a-10a, 11:30a-2pm EST<o:p></o:p></p><p c=
lass=3D"MsoNormal">Thursday (9/24) 9a-11a EST<o:p></o:p></p><p class=3D"MsoNorma=
l">Friday (9/25) 12:30p-3p EST<o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp=
;</o:p></p><p class=3D"MsoNormal">Thanks!<o:p></o:p></p><p class=3D"MsoNormal">J=
ulie<o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><div><div style=
=3D"border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in"><p c=
lass=3D"MsoNormal"><b>From:</b> Marco Rossi &lt;Marco.Rossi@microsoft.com&gt; =
<br><b>Sent:</b> Friday, September 18, 2020 2:02 PM<br><b>To:</b> Elad Yom-T=
ov &lt;eladyt@microsoft.com&gt;; Bessette, Lily Gui &lt;lgbessette@bwh.harva=
rd.edu&gt;<br><b>Cc:</b> Fontanet, Constance P. &lt;cfontanet@bwh.harvard.ed=
u&gt;; Lauffenburger, Julie,PHARM.D.,Ph.D. &lt;JLAUFFENBURGER@BWH.HARVARD.ED=
U&gt;<br><b>Subject:</b> RE: Roybal RL meeting tomorrow at 11:30a EST<o:p></=
o:p></p></div></div><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p><b><span st=
yle=3D"color:white;background:red">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;External Email - Use Caution&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;</span></b><o:p></o:p></p><p class=3D"MsoNormal">Hi All,<o:p></o:p></p><p=
 class=3D"MsoNormal">Thank you Elad for adding me to the thread.<o:p></o:p></p=
><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNormal">My answers i=
n <span style=3D"color:#4472C4">blue </span>below. Let me know if they make se=
nse.<o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNo=
rmal">Thanks,<o:p></o:p></p><p class=3D"MsoNormal">Marco<o:p></o:p></p><p clas=
s=3D"MsoNormal"><o:p>&nbsp;</o:p></p><div><div style=3D"border:none;border-top:s=
olid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in"><p class=3D"MsoNormal"><b>From:<=
/b> Elad Yom-Tov &lt;<a href=3D"mailto:eladyt@microsoft.com">eladyt@microsoft.=
com</a>&gt; <br><b>Sent:</b> Thursday, September 17, 2020 6:29 AM<br><b>To:<=
/b> Bessette, Lily Gui &lt;<a href=3D"mailto:lgbessette@bwh.harvard.edu">lgbes=
sette@bwh.harvard.edu</a>&gt;; Marco Rossi &lt;<a href=3D"mailto:Marco.Rossi@m=
icrosoft.com">Marco.Rossi@microsoft.com</a>&gt;<br><b>Cc:</b> Fontanet, Cons=
tance P. &lt;<a href=3D"mailto:cfontanet@bwh.harvard.edu">cfontanet@bwh.harvar=
d.edu</a>&gt;; Lauffenburger, Julie,PHARM.D.,Ph.D. &lt;<a href=3D"mailto:JLAUF=
FENBURGER@BWH.HARVARD.EDU">JLAUFFENBURGER@BWH.HARVARD.EDU</a>&gt;<br><b>Subj=
ect:</b> RE: Roybal RL meeting tomorrow at 11:30a EST<o:p></o:p></p></div></=
div><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNormal">Hi Lily,<=
o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNormal"=
>(Adding Marco to the thread)<o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;=
</o:p></p><p class=3D"MsoNormal"><a id=3D"OWAAMA255A510393C4CDE978AE67926F44511"=
 href=3D"mailto:Marco.Rossi@microsoft.com"><span style=3D"font-family:&quot;Cali=
bri&quot;,sans-serif;text-decoration:none">@Marco </span></a>Could you addre=
ss questions 1, 2, 4 below?<o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</=
o:p></p><p class=3D"MsoNormal">My answers are below, in red.<o:p></o:p></p><p =
class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNormal">Thanks,<o:p></o:=
p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNormal">Elad<o:=
p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><div><div style=3D"borde=
r:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in"><p class=3D"M=
soNormal"><b>From:</b> Bessette, Lily Gui &lt;<a href=3D"mailto:lgbessette@bwh=
.harvard.edu">lgbessette@bwh.harvard.edu</a>&gt; <br><b>Sent:</b> Thursday, =
17 September 2020 2:29<br><b>To:</b> Elad Yom-Tov &lt;<a href=3D"mailto:eladyt=
@microsoft.com">eladyt@microsoft.com</a>&gt;<br><b>Cc:</b> Fontanet, Constan=
ce P. &lt;<a href=3D"mailto:cfontanet@bwh.harvard.edu">cfontanet@bwh.harvard.e=
du</a>&gt;; Lauffenburger, Julie,PHARM.D.,Ph.D. &lt;<a href=3D"mailto:JLAUFFEN=
BURGER@BWH.HARVARD.EDU">JLAUFFENBURGER@BWH.HARVARD.EDU</a>&gt;<br><b>Subject=
:</b> Re: Roybal RL meeting tomorrow at 11:30a EST<o:p></o:p></p></div></div=
><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNormal">Hi Elad,<o:p=
></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNormal">I=E2=
=80=99m starting to code everything for the Reinforcement Learning Project and I=
 have a few questions that have come up.<o:p></o:p></p><p class=3D"MsoNormal">=
<o:p>&nbsp;</o:p></p><ul style=3D"margin-top:0in" type=3D"disc"><li class=3D"MsoLi=
stParagraph" style=3D"margin-left:0in;mso-list:l3 level1 lfo1">First, we were =
wondering if categorizing the features with Namespaces makes any difference =
to the model and if so, what are the advantages and disadvantages in doing s=
o? (<a href=3D"https://nam06.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F=
%2Fdocs.microsoft.com%2Fen-us%2Fazure%2Fcognitive-services%2Fpersonalizer%2F=
concepts-features%23categorize-features-with-namespaces&amp;data=3D02%7C01%7CM=
arco.Rossi%40microsoft.com%7C50ace1905b8d4fa9d35208d85b054d9b%7C72f988bf86f1=
41af91ab2d7cd011db47%7C1%7C0%7C637359425660205829&amp;sdata=3DU4FGVoPLau48iBBv=
khiBmKg788vGk1PW0OUB1CmQsg0%3D&amp;reserved=3D0">https://docs.microsoft.com/en=
-us/azure/cognitive-services/personalizer/concepts-features#categorize-featu=
res-with-namespaces</a>) <o:p></o:p></li></ul><p class=3D"MsoNormal" style=3D"ma=
rgin-left:.5in"><span style=3D"color:#4472C4">Namespaces are a way to group fe=
atures for user readability and to perform on-the-fly feature engineering ac=
ross namespaces. There is no disadvantage to using them, with Personalizer y=
ou must use them because the formatting of the json is important. Advantages=
 are the on-the-fly feature engineering. Examples of this:<o:p></o:p></span>=
</p><ul style=3D"margin-top:0in" type=3D"disc"><ol style=3D"margin-top:0in" start=3D=
"1" type=3D"1"><li class=3D"MsoListParagraph" style=3D"color:#4472C4;margin-left:0=
in;mso-list:l3 level2 lfo1">Crossing all the features belonging to two names=
paces: --quadratic AB or --cubic ABC (where A, B, and C are the initials, ca=
se-sensitive, of the two/three namespaces). Higher order crossing is also av=
ailable.<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"color:#4472C4;ma=
rgin-left:0in;mso-list:l3 level2 lfo1">Ignore a namespace: --ignore A (A is =
the initial of the namespace to be ignored)<o:p></o:p></li></ol></ul><p clas=
s=3D"MsoListParagraph" style=3D"margin-left:1.0in"><span style=3D"color:#4472C4"><=
o:p>&nbsp;</o:p></span></p><ul style=3D"margin-top:0in" type=3D"disc"><li class=3D=
"MsoListParagraph" style=3D"margin-left:0in;mso-list:l3 level1 lfo1">Additiona=
lly, in terms of denseness of our features, should we convert any of our con=
tinuous variables i.e. Age, HbA1c, etc. into buckets/categorical variables? =
Or are they okay as-is as continuous variables? (<a href=3D"https://nam06.safe=
links.protection.outlook.com/?url=3Dhttps%3A%2F%2Fdocs.microsoft.com%2Fen-us%2=
Fazure%2Fcognitive-services%2Fpersonalizer%2Fconcepts-features%23make-featur=
es-more-dense&amp;data=3D02%7C01%7CMarco.Rossi%40microsoft.com%7C50ace1905b8d4=
fa9d35208d85b054d9b%7C72f988bf86f141af91ab2d7cd011db47%7C1%7C0%7C63735942566=
0205829&amp;sdata=3DBqDiBr4c5qzv5tJo00QoNU2b%2B%2BAimpMsNfXQDpmuj7Q%3D&amp;res=
erved=3D0">https://docs.microsoft.com/en-us/azure/cognitive-services/personali=
zer/concepts-features#make-features-more-dense</a>)<o:p></o:p></li></ul><p c=
lass=3D"MsoNormal" style=3D"margin-left:.5in"><span style=3D"color:#4472C4">This i=
s a very important decision. Performance of the algo will be determined by h=
ow we featurize these variables, and these decisions will determine the ML m=
odel size. In general, since we will be operating in the very low data regim=
e, having a small model is probably a must for our scenario. We can schedule=
 a meeting to go over all the features and take an initial decision on how t=
o featurize them.</span> <o:p></o:p></p><ul style=3D"margin-top:0in" type=3D"dis=
c"><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l3 level1 lf=
o1">We also wanted to confirm that the =E2=80=9Chidden factors for evaluation=E2=80=9D a=
re not incorporated anywhere in the Rank calls of within the contextFeatures=
. i.e. These are only for post study analysis and will not contribute to the=
 text message choices.<o:p></o:p></li></ul><p class=3D"MsoNormal"><span style=3D=
"color:red">That is correct.<o:p></o:p></span></p><ul style=3D"margin-top:0in"=
 type=3D"disc"><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l3=
 level1 lfo1">Another clarification I had is whether eventIDs with missing/n=
ull reward values automatically get assumed to be 0 in Personalizer. <span s=
tyle=3D"color:#4472C4">Yes, this is correct.</span> Therefore, if a patient is=
 missing all doses for a day =E2=80=93 i.e. reward result of 0 =E2=80=93 then should I n=
ot send the Reward call of 0 for that eventID incase it is due to a technolo=
gical glitch (i.e. loss of internet connection) and we want to update the Re=
ward appropriately if data later becomes available? In general, what should =
happen when we=E2=80=99re missing pill bottle data for a patient?<o:p></o:p></li><=
/ul><p class=3D"MsoNormal" style=3D"margin-left:.5in"><span style=3D"color:#4472C4=
">If patient is missing all doses, then you don=E2=80=99t need to call the reward =
API. A default reward of 0 will be joined when the Reward Window expires. On=
ce that window expires you cannot send a new reward.<o:p></o:p></span></p><p=
 class=3D"MsoNormal" style=3D"mso-margin-top-alt:0in;margin-right:0in;margin-bot=
tom:12.0pt;margin-left:.5in"><span style=3D"color:#4472C4">How to deal with a =
technological glich is a good question. First of all, do we have visibility =
over these kind of communication errors?<br><br><o:p></o:p></span></p><ul st=
yle=3D"margin-top:0in" type=3D"disc"><li class=3D"MsoListParagraph" style=3D"margin-=
left:0in;mso-list:l3 level1 lfo1">Again confirming the sequential approach t=
o our rank calls:<o:p></o:p></li><ol style=3D"margin-top:0in" start=3D"1" type=3D"=
1"><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l3 level2 lf=
o1">Rank call for Framing =E2=80=93 Pos/Neg/Neutral<o:p></o:p></li><li class=3D"MsoL=
istParagraph" style=3D"margin-left:0in;mso-list:l3 level2 lfo1">Receive and ad=
d resulting Framing choice/response from RankRequest call to Context Feature=
s<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-lis=
t:l3 level2 lfo1">Rank call for History =E2=80=93 Y/N<o:p></o:p></li><li class=3D"Ms=
oListParagraph" style=3D"margin-left:0in;mso-list:l3 level2 lfo1">Receive and =
add resulting History choice/response from RankRequest call to Context Featu=
res<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-l=
ist:l3 level2 lfo1">Rank call for Social =E2=80=93 Y/N<o:p></o:p></li><li class=3D"M=
soListParagraph" style=3D"margin-left:0in;mso-list:l3 level2 lfo1">Receive and=
 add resulting Social choice/response from RankRequest call to Context Featu=
res<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-l=
ist:l3 level2 lfo1">Rank call for Content =E2=80=93 Y/N<o:p></o:p></li><li class=3D"=
MsoListParagraph" style=3D"margin-left:0in;mso-list:l3 level2 lfo1">Receive an=
d add resulting Content choice/response from RankRequest call to Context Fea=
tures<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso=
-list:l3 level2 lfo1">Rank call for Reflective =E2=80=93 Y/N<o:p></o:p></li><li cl=
ass=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l3 level2 lfo1">Recei=
ve resulting Reflective choice/response from RankRequest call.<o:p></o:p></l=
i><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l3 level2 lfo=
1">Use resulting combination of framing, history, social, content, reflectiv=
e action responses to choose the unique factor set of text messages.<o:p></o=
:p></li><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l3 leve=
l2 lfo1">Randomly choose one out of the two/three messages in that unique fa=
ctor set.<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"margin-left:0in=
;mso-list:l3 level2 lfo1">Record this data and output the chosen text messag=
e for this eventID.<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"margi=
n-left:0in;mso-list:l3 level2 lfo1">Use this data to update number of days s=
ince each type (framing/history/social/content/reflective) of message was se=
nt.<o:p></o:p></li></ol></ul><p class=3D"MsoNormal"><span style=3D"color:red">Th=
is is correct.<o:p></o:p></span></p><ul style=3D"margin-top:0in" type=3D"disc"><=
li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l3 level1 lfo1">=
For <span style=3D"background:yellow;mso-highlight:yellow">@Julie</span>, to t=
hink on, we=E2=80=99re also debating whether we should have which medications they=
 are using as part of the contextFeatures =E2=80=93 i.e. Metformin Yes/No due to v=
ariations in pill size etc. and their possible influence on adherence. <o:p>=
</o:p></li><li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l3 l=
evel1 lfo1">Also, more of a <span style=3D"background:yellow;mso-highlight:yel=
low">@Julie</span> question, I thought about the calendar day idea for asses=
sing reward result. To confirm, we are saying that if a patient took their m=
edication appropriately (i.e. all doses) on 9/16/2020 and the text message w=
as sent on 9/16/2020, then reward is 1. It is NOT if the text message was se=
nt on 9/15/2020 and then the patient took all their doses appropriately on 9=
/16/2020 that we are evaluating, correct? My other thought here is, do we ca=
re if the text message (i.e. 5pm 9/16/2020) was received later on the same d=
ay that they took their medication (i.e. 6am 9/16/2020)? Just thinking throu=
gh the timing of everything to make sure I=E2=80=99m not missing something in rega=
rds to choosing a 24 hr window vs a calendar day assessment for reward. <o:p=
></o:p></li></ul><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><p class=3D"MsoNorm=
al">Let me know if any of this doesn=E2=80=99t make sense and if you=E2=80=99d prefer to=
 meet via Zoom to discuss.<o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o=
:p></p><p class=3D"MsoNormal">Thank you!<o:p></o:p></p><p class=3D"MsoNormal">Be=
st,<br>Lily<o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><div><p =
class=3D"MsoNormal"><b><span style=3D"color:black">Lily Bessette</span></b><span=
 style=3D"color:black"><br><i>Project Coordinator&nbsp;<br></i>Division of Pha=
rmacoepidemiology and Pharmacoeconomics&nbsp;<br>Department of Medicine<i>&n=
bsp;<br></i>Brigham and Women's Hospital&nbsp; | Harvard Medical School<o:p>=
</o:p></span></p><p class=3D"MsoNormal"><span style=3D"color:black">41 Avenue Lo=
uis Pasteur,&nbsp; Suite 116, Boston, MA 02115<o:p></o:p></span></p><p class=
=3D"MsoNormal"><span style=3D"color:black">p. (617) 264-3099 |<i>&nbsp;<a href=3D"=
mailto:lgbessette@bwh.harvard.edu"><span style=3D"font-style:normal">lgbessett=
e@bwh.harvard.edu</span></a></i> |<a href=3D"https://nam06.safelinks.protectio=
n.outlook.com/?url=3Dhttps%3A%2F%2Fforms.gle%2Fys3kZsb6muWcat5F8&amp;data=3D02%7=
C01%7CMarco.Rossi%40microsoft.com%7C50ace1905b8d4fa9d35208d85b054d9b%7C72f98=
8bf86f141af91ab2d7cd011db47%7C1%7C0%7C637359425660215818&amp;sdata=3Dr0%2BdkE7=
Hi8PwdEWeGR0aPXRiZk34I7WQXu6ITVVbwH8%3D&amp;reserved=3D0">Research Assistant R=
equest Form</a><o:p></o:p></span></p></div><p class=3D"MsoNormal"><span style=3D=
"color:#212121"><img border=3D"0" width=3D"289" height=3D"46" style=3D"width:3.0104i=
n;height:.4791in" id=3D"Picture_x0020_1" src=3D"cid:image001.png@01D68DD0.12D19F=
50"></span><o:p></o:p></p><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p><div sty=
le=3D"border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in"><p=
 class=3D"MsoNormal"><b><span style=3D"font-size:12.0pt;color:black">From: </spa=
n></b><span style=3D"font-size:12.0pt;color:black">&quot;Lauffenburger, Julie,=
PHARM.D.,Ph.D.&quot; &lt;<a href=3D"mailto:JLAUFFENBURGER@BWH.HARVARD.EDU">JLA=
UFFENBURGER@BWH.HARVARD.EDU</a>&gt;<br><b>Date: </b>Wednesday, September 9, =
2020 at 1:39 PM<br><b>To: </b>&quot;McDonnell, Marie E.,M.D.&quot; &lt;<a hr=
ef=3D"mailto:MMCDONNELL@BWH.HARVARD.EDU">MMCDONNELL@BWH.HARVARD.EDU</a>&gt;, &=
quot;Choudhry, Niteesh Kumar,M.D.,Ph.D.&quot; &lt;<a href=3D"mailto:NKCHOUDHRY=
@BWH.HARVARD.EDU">NKCHOUDHRY@BWH.HARVARD.EDU</a>&gt;, Elad Yom-Tov &lt;<a hr=
ef=3D"mailto:eladyt@microsoft.com">eladyt@microsoft.com</a>&gt;, &quot;Keller,=
 Punam A.&quot; &lt;<a href=3D"mailto:Punam.A.Keller@tuck.dartmouth.edu">Punam=
.A.Keller@tuck.dartmouth.edu</a>&gt;<br><b>Cc: </b>&quot;Barlev, Renee A.&qu=
ot; &lt;<a href=3D"mailto:rbarlev@bwh.harvard.edu">rbarlev@bwh.harvard.edu</a>=
&gt;, &quot;Haff, Nancy,M.D.&quot; &lt;<a href=3D"mailto:NHAFF@PARTNERS.ORG">N=
HAFF@PARTNERS.ORG</a>&gt;, &quot;<a href=3D"mailto:philip.rosenfield@microsoft=
.com">philip.rosenfield@microsoft.com</a>&quot; &lt;<a href=3D"mailto:philip.r=
osenfield@microsoft.com">philip.rosenfield@microsoft.com</a>&gt;, &quot;Hank=
en, Kaitlin Elizabeth&quot; &lt;<a href=3D"mailto:khanken@bwh.harvard.edu">kha=
nken@bwh.harvard.edu</a>&gt;, &quot;Sears, Ellen Sawka&quot; &lt;<a href=3D"ma=
ilto:essears@bwh.harvard.edu">essears@bwh.harvard.edu</a>&gt;, &quot;Fontane=
t, Constance P.&quot; &lt;<a href=3D"mailto:cfontanet@bwh.harvard.edu">cfontan=
et@bwh.harvard.edu</a>&gt;, &quot;Kim, Erin&quot; &lt;<a href=3D"mailto:ekim55=
@bwh.harvard.edu">ekim55@bwh.harvard.edu</a>&gt;, &quot;Bessette, Lily Gui&q=
uot; &lt;<a href=3D"mailto:lgbessette@bwh.harvard.edu">lgbessette@bwh.harvard.=
edu</a>&gt;<br><b>Subject: </b>Roybal RL meeting tomorrow at 11:30a EST<o:p>=
</o:p></span></p></div><div><p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p></div>=
<p class=3D"MsoNormal">Hi everyone,<o:p></o:p></p><p class=3D"MsoNormal">&nbsp;<=
o:p></o:p></p><p class=3D"MsoNormal">I hope you all are doing well. We=E2=80=99re pl=
anning to use our 30 minutes tomorrow to review the algorithm development wi=
thin the Azure platform. If you have interested in attending, feel free, but=
 the plan is to focus on that. Thanks!<o:p></o:p></p><p class=3D"MsoNormal">&n=
bsp;<o:p></o:p></p><p class=3D"MsoNormal">Other study updates:<o:p></o:p></p><=
ul style=3D"margin-top:0in" type=3D"disc"><li class=3D"MsoListParagraph" style=3D"ma=
rgin-left:0in;mso-list:l1 level1 lfo2">All regulatory, IRB, and RISO approva=
ls have been obtained.<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"ma=
rgin-left:0in;mso-list:l1 level1 lfo2">We=E2=80=99ve received the pillbottles and =
pillbottle caps! Everything with regard to mailing the pillbottles is basica=
lly ready to go.<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"margin-l=
eft:0in;mso-list:l1 level1 lfo2">The text messaging platform environment is =
being set up for us now (and text messages have been finalized). We expect t=
o set up the texts within the next few weeks.<o:p></o:p></li><li class=3D"MsoL=
istParagraph" style=3D"margin-left:0in;mso-list:l1 level1 lfo2">The REDCap dat=
abase and other patient recruitment components are in process, nearing compl=
etion. <o:p></o:p></li></ul><p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><p cla=
ss=3D"MsoNormal">I=E2=80=99ve also included our minutes from last time. Thanks!<o:p>=
</o:p></p><p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><div><p class=3D"MsoNormal=
">Best,<o:p></o:p></p><p class=3D"MsoNormal">Julie <o:p></o:p></p><p class=3D"Ms=
oNormal">&nbsp;<o:p></o:p></p><p class=3D"MsoNormal">--<o:p></o:p></p><p class=
=3D"MsoNormal">Julie Lauffenburger, PharmD, PhD<o:p></o:p></p><p class=3D"MsoNor=
mal">617-525-8865<o:p></o:p></p><p class=3D"MsoNormal"><a href=3D"mailto:jlauffe=
nburger@bwh.harvard.edu">jlauffenburger@bwh.harvard.edu</a><o:p></o:p></p></=
div><p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><div><div style=3D"border:none;b=
order-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in"><p class=3D"MsoNormal=
"><b>From:</b> Lauffenburger, Julie,PHARM.D.,Ph.D. <br><b>Sent:</b> Tuesday,=
 September 01, 2020 4:42 PM<br><b>To:</b> McDonnell, Marie E.,M.D. &lt;<a hr=
ef=3D"mailto:MMCDONNELL@BWH.HARVARD.EDU">MMCDONNELL@BWH.HARVARD.EDU</a>&gt;; C=
houdhry, Niteesh Kumar,M.D.,Ph.D. &lt;<a href=3D"mailto:NKCHOUDHRY@BWH.HARVARD=
.EDU">NKCHOUDHRY@BWH.HARVARD.EDU</a>&gt;; 'Elad Yom-Tov' &lt;<a href=3D"mailto=
:eladyt@microsoft.com">eladyt@microsoft.com</a>&gt;; 'Keller, Punam A.' &lt;=
<a href=3D"mailto:Punam.A.Keller@tuck.dartmouth.edu">Punam.A.Keller@tuck.dartm=
outh.edu</a>&gt;<br><b>Cc:</b> Barlev, Renee A. &lt;<a href=3D"mailto:rbarlev@=
bwh.harvard.edu">rbarlev@bwh.harvard.edu</a>&gt;; Haff, Nancy,M.D. &lt;<a hr=
ef=3D"mailto:NHAFF@PARTNERS.ORG">NHAFF@PARTNERS.ORG</a>&gt;; 'philip.rosenfiel=
d@microsoft.com' &lt;<a href=3D"mailto:philip.rosenfield@microsoft.com">philip=
.rosenfield@microsoft.com</a>&gt;; Hanken, Kaitlin Elizabeth &lt;<a href=3D"ma=
ilto:khanken@bwh.harvard.edu">khanken@bwh.harvard.edu</a>&gt;; Sears, Ellen =
Sawka &lt;<a href=3D"mailto:essears@bwh.harvard.edu">essears@bwh.harvard.edu</=
a>&gt;; Fontanet, Constance P. &lt;<a href=3D"mailto:cfontanet@bwh.harvard.edu=
">cfontanet@bwh.harvard.edu</a>&gt;; Kim, Erin &lt;<a href=3D"mailto:ekim55@bw=
h.harvard.edu">ekim55@bwh.harvard.edu</a>&gt;<br><b>Subject:</b> Updated tex=
t messages for our Roybal pilot<o:p></o:p></p></div></div><p class=3D"MsoNorma=
l">&nbsp;<o:p></o:p></p><p class=3D"MsoNormal">Hi all,<o:p></o:p></p><p class=3D=
"MsoNormal">&nbsp;<o:p></o:p></p><p class=3D"MsoNormal">I=E2=80=99m attaching the up=
dated, hopefully close to final, version of the text messages for our Roybal=
 pilot. Many thanks to all who gave input and helped draft messages, especia=
lly Punam, Kaitlin, and Constance on this round! Any questions, please let m=
e know.<o:p></o:p></p><p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><div><p clas=
s=3D"MsoNormal">Best,<o:p></o:p></p><p class=3D"MsoNormal">Julie <o:p></o:p></p>=
<p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><p class=3D"MsoNormal">--<o:p></o:p>=
</p><p class=3D"MsoNormal">Julie Lauffenburger, PharmD, PhD<o:p></o:p></p><p c=
lass=3D"MsoNormal">617-525-8865<o:p></o:p></p><p class=3D"MsoNormal"><a href=3D"ma=
ilto:jlauffenburger@bwh.harvard.edu">jlauffenburger@bwh.harvard.edu</a><o:p>=
</o:p></p></div><p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><div><div style=3D"b=
order:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in"><p clas=
s=3D"MsoNormal"><b>From:</b> Lauffenburger, Julie,PHARM.D.,Ph.D. <br><b>Sent:<=
/b> Wednesday, August 12, 2020 11:00 AM<br><b>To:</b> McDonnell, Marie E.,M.=
D. &lt;<a href=3D"mailto:MMCDONNELL@BWH.HARVARD.EDU">MMCDONNELL@BWH.HARVARD.ED=
U</a>&gt;; Choudhry, Niteesh Kumar,M.D.,Ph.D. &lt;<a href=3D"mailto:NKCHOUDHRY=
@BWH.HARVARD.EDU">NKCHOUDHRY@BWH.HARVARD.EDU</a>&gt;; Elad Yom-Tov &lt;<a hr=
ef=3D"mailto:eladyt@microsoft.com">eladyt@microsoft.com</a>&gt;; Keller, Punam=
 A. &lt;<a href=3D"mailto:Punam.A.Keller@tuck.dartmouth.edu">Punam.A.Keller@tu=
ck.dartmouth.edu</a>&gt;<br><b>Cc:</b> Barlev, Renee A. &lt;<a href=3D"mailto:=
rbarlev@bwh.harvard.edu">rbarlev@bwh.harvard.edu</a>&gt;; Haff, Nancy,M.D. &=
lt;<a href=3D"mailto:NHAFF@PARTNERS.ORG">NHAFF@PARTNERS.ORG</a>&gt;; <a href=3D"=
mailto:philip.rosenfield@microsoft.com">philip.rosenfield@microsoft.com</a>;=
 Hanken, Kaitlin Elizabeth &lt;<a href=3D"mailto:khanken@bwh.harvard.edu">khan=
ken@bwh.harvard.edu</a>&gt;; Sears, Ellen Sawka &lt;<a href=3D"mailto:essears@=
bwh.harvard.edu">essears@bwh.harvard.edu</a>&gt;; Fontanet, Constance P. &lt=
;<a href=3D"mailto:cfontanet@bwh.harvard.edu">cfontanet@bwh.harvard.edu</a>&gt=
;; Kim, Erin &lt;<a href=3D"mailto:ekim55@bwh.harvard.edu">ekim55@bwh.harvard.=
edu</a>&gt;<br><b>Subject:</b> Roybal Reinforcement learning meeting tomorro=
w at 1pm EST<o:p></o:p></p></div></div><p class=3D"MsoNormal">&nbsp;<o:p></o:p=
></p><p class=3D"MsoNormal">Dear team,<o:p></o:p></p><p class=3D"MsoNormal">&nbs=
p;<o:p></o:p></p><p class=3D"MsoNormal">I=E2=80=99m looking forward to our Reinforce=
ment learning meeting tomorrow (Thurs, 1pm EST). I=E2=80=99ve attached the minutes=
 from our last full call, proposed text messages for review, and a list of p=
otential predictors for discussion. <o:p></o:p></p><p class=3D"MsoNormal">&nbs=
p;<o:p></o:p></p><p class=3D"MsoNormal">Proposed agenda:<o:p></o:p></p><ul sty=
le=3D"margin-top:0in" type=3D"disc"><li class=3D"MsoListParagraph" style=3D"margin-l=
eft:0in;mso-list:l2 level1 lfo3">Brief study updates<o:p></o:p></li><ul styl=
e=3D"margin-top:0in" type=3D"circle"><li class=3D"MsoListParagraph" style=3D"margin-=
left:0in;mso-list:l2 level2 lfo3">Pillsy pillbottles<o:p></o:p></li><li clas=
s=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l2 level2 lfo3">Text me=
ssaging platform<o:p></o:p></li><li class=3D"MsoListParagraph" style=3D"margin-l=
eft:0in;mso-list:l2 level2 lfo3">Algorithm development<o:p></o:p></li></ul><=
li class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l2 level1 lfo3">=
Discussion points<o:p></o:p></li><ul style=3D"margin-top:0in" type=3D"circle"><l=
i class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l2 level2 lfo3">R=
eview proposed text messages (attachment) <o:p></o:p></li><li class=3D"MsoList=
Paragraph" style=3D"margin-left:0in;mso-list:l2 level2 lfo3">Clarify predictio=
n model inputs/elements (attachment)<o:p></o:p></li></ul></ul><p class=3D"MsoN=
ormal">&nbsp;<o:p></o:p></p><p class=3D"MsoNormal">Thanks! Any questions, let =
me know.<o:p></o:p></p><p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><div><p cla=
ss=3D"MsoNormal">Best,<o:p></o:p></p><p class=3D"MsoNormal">Julie <o:p></o:p></p=
><p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><p class=3D"MsoNormal">--<o:p></o:p=
></p><p class=3D"MsoNormal">Julie Lauffenburger, PharmD, PhD<o:p></o:p></p><p =
class=3D"MsoNormal">617-525-8865<o:p></o:p></p><p class=3D"MsoNormal"><a href=3D"m=
ailto:jlauffenburger@bwh.harvard.edu">jlauffenburger@bwh.harvard.edu</a><o:p=
></o:p></p></div><p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><div><div style=3D"=
border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in"><p cla=
ss=3D"MsoNormal"><b>From:</b> Lauffenburger, Julie,PHARM.D.,Ph.D. <br><b>Sent:=
</b> Thursday, August 06, 2020 10:41 AM<br><b>To:</b> McDonnell, Marie E.,M.=
D. &lt;<a href=3D"mailto:MMCDONNELL@BWH.HARVARD.EDU">MMCDONNELL@BWH.HARVARD.ED=
U</a>&gt;; Choudhry, Niteesh Kumar,M.D.,Ph.D. &lt;<a href=3D"mailto:NKCHOUDHRY=
@BWH.HARVARD.EDU">NKCHOUDHRY@BWH.HARVARD.EDU</a>&gt;; Elad Yom-Tov &lt;<a hr=
ef=3D"mailto:eladyt@microsoft.com">eladyt@microsoft.com</a>&gt;; Keller, Punam=
 A. &lt;<a href=3D"mailto:Punam.A.Keller@tuck.dartmouth.edu">Punam.A.Keller@tu=
ck.dartmouth.edu</a>&gt;<br><b>Cc:</b> Barlev, Renee A. &lt;<a href=3D"mailto:=
rbarlev@bwh.harvard.edu">rbarlev@bwh.harvard.edu</a>&gt;; Haff, Nancy,M.D. &=
lt;<a href=3D"mailto:NHAFF@PARTNERS.ORG">NHAFF@PARTNERS.ORG</a>&gt;; <a href=3D"=
mailto:philip.rosenfield@microsoft.com">philip.rosenfield@microsoft.com</a>;=
 Hanken, Kaitlin Elizabeth &lt;<a href=3D"mailto:khanken@bwh.harvard.edu">khan=
ken@bwh.harvard.edu</a>&gt;; Sears, Ellen Sawka &lt;<a href=3D"mailto:essears@=
bwh.harvard.edu">essears@bwh.harvard.edu</a>&gt;; Fontanet, Constance P. &lt=
;<a href=3D"mailto:cfontanet@bwh.harvard.edu">cfontanet@bwh.harvard.edu</a>&gt=
;; Kim, Erin &lt;<a href=3D"mailto:ekim55@bwh.harvard.edu">ekim55@bwh.harvard.=
edu</a>&gt;<br><b>Subject:</b> Roybal Reinforcement learning text messages f=
or review<o:p></o:p></p></div></div><p class=3D"MsoNormal">&nbsp;<o:p></o:p></=
p><p class=3D"MsoNormal">Dear team,<o:p></o:p></p><p class=3D"MsoNormal">&nbsp;<=
o:p></o:p></p><p class=3D"MsoNormal">We=E2=80=99ve been hard at work on the text mes=
sages! <b>I=E2=80=99ve attached the list of proposed text messages for your review=
 (Excel).</b> We=E2=80=99re hoping to finalize these as best as possible after our=
 meeting <u>next Thursday (8/13).</u> <o:p></o:p></p><p class=3D"MsoNormal">&n=
bsp;<o:p></o:p></p><p class=3D"MsoNormal">Notes:<o:p></o:p></p><ul style=3D"marg=
in-top:0in" type=3D"disc"><li class=3D"MsoListParagraph" style=3D"margin-left:0in;=
mso-list:l0 level1 lfo4">We are going with 5 main factors (Framing, Observed=
 feedback, Social, Content, Reflective) <span style=3D"font-family:Wingdings">=
=C3=A0</span> this means we need at least 48 unique text messages to meet all th=
ose levels.<o:p></o:p></li><ul style=3D"margin-top:0in" type=3D"circle"><li clas=
s=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l0 level2 lfo4">For eac=
h level, we added a second message, so that there could be more variation, b=
ringing us to a total of 96 messages.<o:p></o:p></li><li class=3D"MsoListParag=
raph" style=3D"margin-left:0in;mso-list:l0 level2 lfo4">Observed feedback: We =
decided to stick with the past 7 days for simplicity.<o:p></o:p></li></ul><l=
i class=3D"MsoListParagraph" style=3D"margin-left:0in;mso-list:l0 level1 lfo4">T=
he =E2=80=9CHidden=E2=80=9D factors are other variables that could be evaluated post-hoc=
, so each message is also coded for whether it meets any of those criteria (=
for example: quantitative or doctor), but we do not have to have unique mess=
ages for these.<o:p></o:p></li></ul><p class=3D"MsoNormal">&nbsp;<o:p></o:p></=
p><p class=3D"MsoNormal"><b>Specific ask: </b>Please review these messages and=
 suggest any modifications; most happy to also entertain other options or re=
placements!<o:p></o:p></p><p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><p class=
=3D"MsoNormal">Huge thanks to Kaitlin, Ellen, Constance, and our other RA, Eri=
n, for their help with these! I=E2=80=99ve also attached our July meeting minutes =
as a refresher. Any questions, please let me know. Thank you!<o:p></o:p></p>=
<p class=3D"MsoNormal">&nbsp;<o:p></o:p></p><div><p class=3D"MsoNormal">Best,<o:=
p></o:p></p><p class=3D"MsoNormal">Julie <o:p></o:p></p></div><div><p class=3D"M=
soNormal">The information in this e-mail is intended only for the person to =
whom it is addressed. If you believe this e-mail was sent to you in error an=
d the e-mail contains patient information, please contact the Mass General B=
righam Compliance HelpLine at <a href=3D"https://nam06.safelinks.protection.ou=
tlook.com/?url=3Dhttp%3A%2F%2Fwww.massgeneralbrigham.org%2Fcomplianceline&amp;=
data=3D02%7C01%7CMarco.Rossi%40microsoft.com%7C50ace1905b8d4fa9d35208d85b054d9=
b%7C72f988bf86f141af91ab2d7cd011db47%7C1%7C0%7C637359425660215818&amp;sdata=3D=
OAKQyQO4E0Wg0J3tUkIS0EWEde%2FDIwvIvUaKjfTvTBg%3D&amp;reserved=3D0">http://www.=
massgeneralbrigham.org/complianceline</a> . If the e-mail was sent to you in=
 error but does not contain patient information, please contact the sender a=
nd properly dispose of the e-mail.<o:p></o:p></p></div></div></body></html>

--B_3687283027_1678704601--


--B_3687283027_1649149280
Content-type: image/png; name="image001.png";
 x-mac-creator="4F50494D";
 x-mac-type="504E4766"
Content-ID: <image001.png@01D68DD0.12D19F50>
Content-disposition: inline;
	filename="image001.png"
Content-transfer-encoding: base64
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8eeKE9IajWhP2i0Dofzp5ylJEURH6hgzKJ6Fq4spOFKBMciXF1nFcXk9jB+WxR2TulNXU891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--B_3687283027_1649149280--

